Minerva surgical announces $30 million private placement of common stock led by accelmed partners

Santa clara, calif., dec. 27, 2022 (globe newswire) -- minerva surgical, inc. (nasdaq: utrs) (minerva surgical or the company), a women's health company focused on the treatment of abnormal uterine bleeding (aub), announced today that it has entered into a share purchase agreement for the sale of 146,627,565 shares (subject to adjustment for any stock split occurring prior to closing) of its common stock in a private placement, led by accelmed, with participation by new enterprise associates, at an offering price of $0.2046 per share (subject to adjustment for any stock split occurring prior to closing). following the offering, accelmed will become the controlling stockholder of minerva surgical.
UTRS Ratings Summary
UTRS Quant Ranking